Web Search

  1. Results from the WOW.Com Content Network
  2. Steven H. Collis - Wikipedia

    Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. Early life. Collis was born in South Africa and attended the University of Witwatersrand, where he earned a Bachelor of Commerce. Collis is Jewish. Career

  3. Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

    For premium support please call: 800-290-4726 more ways to reach us

  4. Cencora - Wikipedia

    AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue. History. AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation.

  5. Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

    Need help? Call us! 800-290-4726 Login / Join. Mail

  6. AmerisourceBergen Approves Quarterly Dividend - AOL

    AmerisourceBergen Approves Quarterly Dividend VALLEY FORGE, Pa.--(BUSINESS WIRE)-- The Board of Directors of AmerisourceBergen Corporation (NYS: ABC) today declared a cash dividend of $0.21 per ...

  7. What's in Store for AmerisourceBergen (ABC) in Q2 Earnings? - AOL

    Better-than-expected performance at Pharmaceutical Distribution and World Courier and higher revenues might aid AmerisourceBergen (ABC) in Q2 earnings. However, stiff competition might be a dampener.

  8. AmerisourceBergen (ABC) Soars to 52-Week High, Time to ... - AOL

    AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  9. AmerisourceBergen (ABC) Tops Q2 Earnings and Revenue ... - AOL

    AmerisourceBergen (ABC) delivered earnings and revenue surprises of 5.26% and 3.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?